Menopausal hormone therapy update
| Sunday, May 31, 2026 |
| 11:40 AM - 12:20 PM |
| Royal Benowa Ballroom |
Overview
Dr Karen Magraith
Details
Menopausal hormone therapy (MHT) remains an important option for managing vasomotor and other menopausal symptoms. This session provides an evidence-based update on the current role of MHT, including indications, risks and benefits, prescribing considerations, and individualised monitoring strategies to support safe and effective care.
Learning Objectives
• Identify the indications for menopausal hormone therapy.
• Discuss prescribing considerations, including formulation, dose and route of administration.
• Recognise how MHT is monitored and tailored to individual patient needs over time.
Competency Standards (2016): 2.4, 3.1, 3.3
Speaker
Dr Karen Magraith
General Practitioner
Cascade Road General Practice
MHT Update
Biography
Dr Karen Magraith BMBS FRACGP is a GP in Hobart. She is a past president of the Australasian Menopause Society. She is a committee member of the Medical and Scientific Advisory Committee for Health Bones Australia. Long version: Dr Karen Magraith BMBS FRACGP is a GP in Hobart. She is a past president of the Australasian Menopause Society. She is a committee member of the Medical and Scientific Advisory Committee for Health Bones Australia. Her focus is on GP education and translating academic content into practical information for clinicians.
